These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15023729)

  • 1. Successful treatment of diffuse alveolar hemorrhage with activated factor VII.
    Henke D; Falk RJ; Gabriel DA
    Ann Intern Med; 2004 Mar; 140(6):493-4. PubMed ID: 15023729
    [No Abstract]   [Full Text] [Related]  

  • 2. Diffuse alveolar hemorrhage after allogeneic hematopoietic stem-cell transplantation: treatment with recombinant factor VIIa.
    Pastores SM; Papadopoulos E; Voigt L; Halpern NA
    Chest; 2003 Dec; 124(6):2400-3. PubMed ID: 14665531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of recombinant activated factor VII in diffuse alveolar haemorrhage].
    Dabar G; Harmouche C; Jammal M
    Rev Mal Respir; 2011 Jan; 28(1):106-11. PubMed ID: 21277485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrabronchial administration of activated recombinant factor VII in a young child with diffuse alveolar hemorrhage.
    Larcombe PJ; Kapur N; Fraser CJ; Coulthard MG; Schlapbach LJ
    Pediatr Blood Cancer; 2014 Mar; 61(3):570-1. PubMed ID: 24424793
    [No Abstract]   [Full Text] [Related]  

  • 5. Bronchoscopic instillation of activated recombinant factor VII to treat diffuse alveolar hemorrhage in a child.
    Colin AA; Shafieian M; Andreansky M
    Pediatr Pulmonol; 2010 Apr; 45(4):411. PubMed ID: 20187104
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of diffuse alveolar hemorrhage in systemic lupus erythematosus patient with local pulmonary administration of factor VIIa (rFVIIa): a case report.
    Alabed IB
    Medicine (Baltimore); 2014 Sep; 93(14):e72. PubMed ID: 25255019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful pulmonary administration of activated recombinant factor VII in diffuse alveolar hemorrhage.
    Heslet L; Nielsen JD; Levi M; Sengeløv H; Johansson PI
    Crit Care; 2006; 10(6):R177. PubMed ID: 17184515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant factor VIIa to treat diffuse alveolar hemorrhage following allogeneic stem cell transplantation.
    Shenoy A; Savani BN; Barrett AJ
    Biol Blood Marrow Transplant; 2007 May; 13(5):622-3. PubMed ID: 17448923
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of Activated Factor VII in Patients with Diffuse Alveolar Hemorrhage: A 10 Years Institutional Experience.
    Pathak V; Kuhn J; Gabriel D; Barrow J; Jennette JC; Henke DC
    Lung; 2015 Jun; 193(3):375-9. PubMed ID: 25802198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor viia for alveolar hemorrhage in microscopic polyangiitis.
    Betensley AD; Yankaskas JR
    Am J Respir Crit Care Med; 2002 Nov; 166(9):1291-2. PubMed ID: 12403702
    [No Abstract]   [Full Text] [Related]  

  • 11. Intrapulmonary Recombinant Factor VII as an Effective Treatment for Diffuse Alveolar Hemorrhage: A Case Series.
    Baker MS; Diab KJ; Carlos WG; Mathur P
    J Bronchology Interv Pulmonol; 2016 Jul; 23(3):255-8. PubMed ID: 27261934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Diffuse Alveolar Hemorrhage: Controlling Inflammation and Obtaining Rapid and Effective Hemostasis.
    Park JA
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffuse alveolar hemorrhage.
    Baumgartner M; Ashton R
    South Med J; 2011 Apr; 104(4):274-5. PubMed ID: 21606696
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of Novoseven for arsenic trioxide-induced bleeding in PML.
    Alimoghaddam K; Ghavamzadeh A; Jahani M
    Am J Hematol; 2006 Sep; 81(9):720. PubMed ID: 16804937
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful use of recombinant activated factor VII in controlling upper gastrointestinal bleeding in a patient with relapsed acute myeloid leukemia.
    Hoffman R; Eliakim R; Zuckerman T; Rowe JM; Brenner B
    J Thromb Haemost; 2003 Mar; 1(3):606-8. PubMed ID: 12871480
    [No Abstract]   [Full Text] [Related]  

  • 16. Corticosteroid therapy for diffuse alveolar hemorrhage in autologous bone marrow transplant recipients.
    Chao NJ; Duncan SR; Long GD; Horning SJ; Blume KG
    Ann Intern Med; 1991 Jan; 114(2):145-6. PubMed ID: 1984392
    [No Abstract]   [Full Text] [Related]  

  • 17. Diffuse alveolar haemorrhage in a systemic lupus erythematosus patient successfully treated with rituximab: a case report.
    Nellessen CM; Pöge U; Brensing KA; Sauerbruch T; Klehr HU; Rabe C
    Nephrol Dial Transplant; 2008 Jan; 23(1):385-6. PubMed ID: 17933839
    [No Abstract]   [Full Text] [Related]  

  • 18. Parenteral use of recombinant activated factor VII during diffuse alveolar hemorrhage secondary to leptospirosis.
    Tatopoulos A; Herbain D; Kazmierczak C; Bollaert PE; Gibot S
    Intensive Care Med; 2010 Mar; 36(3):555-6. PubMed ID: 19924396
    [No Abstract]   [Full Text] [Related]  

  • 19. Recombinant activated factor VII (NovoSeven) stops severe intra-abdominal bleeding after liver needle biopsy without surgery.
    Sendensky A; Gutzwiller JP; Schneider-Frost J; Wuillemin WA; Graeni R; Beglinger C
    Blood Coagul Fibrinolysis; 2004 Oct; 15(8):701-2. PubMed ID: 15613927
    [No Abstract]   [Full Text] [Related]  

  • 20. Effective treatment of severe bleeding due to acquired thrombocytopathia by single dose administration of activated recombinant factor VII.
    Meijer K; Sieders E; Slooff MJ; de Wolf JT; van der Meer J
    Thromb Haemost; 1998 Jul; 80(1):204-5. PubMed ID: 9684815
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.